Sweat Testing
[Sweat Testing]
EPTIS Ringversuch Nr. 1616150 | Letze Änderung 2026-09-24 | URL: https://www.eptis.bam.de/pts1616150 https://www.eptis.bam.de/pts1616150
| Name des Anbieters | |||||||||||||||||||
| Name des Anbieters | Birmingham Quality (member of the UK NEQAS Consortium), University Hospitals Birmingham NHS Foundation Trust Birmingham Quality (member of the UK NEQAS Consortium), University Hospitals Birmingham NHS Foundation Trust | ||||||||||||||||||
| Ansässig in | United Kingdom | ||||||||||||||||||
| Sprache(n) | English | ||||||||||||||||||
| Anmerkungen | Provides EQA coverage for Sweat Chloride, Conductivity and Sodium testing. Sweat Chloride testing is performed as part of the diagnostic pathway for Cystic Fibrosis; some laboratories also measure Conductivity and Sodium as part of sweat assessment. The scheme provides assessment of analytical performance but also includes an interpretative element for Sweat Chloride and Conductivity, based on a clinical scenario given at each distribution, which assesses variation in the guidelines followed by participants in the scheme. | ||||||||||||||||||
| Klassifizierung | |||||||||||||||||||
| Produktgruppen |
Human test material
|
||||||||||||||||||
| Prüfgebiete |
Medical analysis
|
||||||||||||||||||
| Technische Einzelheiten | |||||||||||||||||||
|
|||||||||||||||||||
| Ringversuchsziele | |||||||||||||||||||
| Zielgruppe des Ringversuchs | Clinical Chemistry Public & Private Labs | ||||||||||||||||||
| Relevante Rechtsvorschriften oder Normen | ISO/IEC 17043:2023 | ||||||||||||||||||
| Weitere Ziele | Post market surveillance of testing methods | ||||||||||||||||||
| Teilnehmerzahl | |||||||||||||||||||
| Anbieter unabhängig überprüft (akkreditiert, benannt, anerkannt) |
Akkreditiert durch UKAS auf der Grundlage von ISO/IEC 17043:2023 |
||||||||||||||||||
| Die Durchführung des Ringversuchs ist in Auftrag gegeben durch | |||||||||||||||||||
| Kosten | |||||||||||||||||||
| Teilnahmegebühr | Contact provider for current fee, which depends on location and extent of service required. | ||||||||||||||||||
| Regelmässig durchgeführt | Ja (Monthly (11 per year)) | ||||||||||||||||||
| Der Ringversuch wird durchgeführt seit | 1999 | ||||||||||||||||||
| Kontaktdaten des Anbieters | |||||||||||||||||||
| Anbieter | Kontaktperson | ||||||||||||||||||
|
Birmingham Quality (member of the UK NEQAS Consortium), University Hospitals Birmingham NHS Foundation Trust
Queen Elizabeth Medical Centre P O Box 3909 B15 2SQ Birmingham United Kingdom Telefon: +44 121 414 7300 Fax: Web: https://www.birminghamquality.org.uk https://www.birminghamquality.org.uk |
Birmingham Quality
Telefon: +44 121 414 7300 Fax: E-Mail: birminghamquality@uhb.nhs.uk birminghamquality@uhb.nhs.uk |
||||||||||||||||||
Haben Sie einen Fehler entdeckt? Bitte wenden Sie sich an den zuständigen EPTIS Koordinator für United Kingdom,
Mr Savvas Xystouris.
Mr Savvas Xystouris.